SA
Insider buying
Srinivas Akkaraju bought $1.2M of KLRS stock
Srinivas Akkaraju, Dir, 10% of Kalaris Therapeutics, Inc. (KLRS), bought 244,300 shares of KLRS stock worth $1.2M, per an SEC Form 4 filed May 22, 2026.
The shares came through a private deal, not the open market.
The trade happened on May 20, 2026, 2 days before it was made public.
KLRS has moved -58.8% since the trade date, from $4.83 to $1.99 (Oct 22, 2026 close).
- Traded
- May 20, 2026
- Disclosed
- May 22, 2026
- Filing delay
- 2 days
- Price since
- -58.8%
- Role
- Dir, 10%
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.